Dealing with a new diagnosis or confusing lab numbers? Talk with people who have been there. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data
← All Conditions (3,135) / Anemia, Clotting & Blood Disorders

Anemia, Clotting & Blood Disorders (88 Condition Guides)

Iron-deficiency and B12 anemia, sickle cell disease, clotting disorders, and hematology.

Interactive MyChart Lab & Cuff Translator • Lab Bell-Curve “Normal” vs. Physiological Optimal

Why Your Portal Says “Normal” When You Still Feel Awful: Enter Your Number

Quest and LabCorp “Normal” ranges are 95% population bell curves—not physiological optimums. Select a marker and type your result below:

3-Zone Clinical Cutoff Audit • Serum Ferritin (Iron Storage)

18 ng/mL = Marked "Normal" by Lab, Yet Clinically Depleted (< 30–50 ng/mL)

Default Sample: 18 ng/mL
Zone 1 • Clinical Cutoff
< 15 ng/mL • Overt Deficiency
< 15 ng/mL (Absolute Depletion)
Zone 2 • Portal “Normal” Gray Zone
15–49 ng/mL • "Normal" Yet Depleted
15–150 ng/mL (Quest/LabCorp Bell Curve)
Zone 3 • Physiological Optimal
50–100 ng/mL • Clinical Optimal
50–100 ng/mL (Physiological Optimal)
What This Number Means in Plain English

Commercial labs only flag Ferritin below 15 ng/mL, but clinical trials confirm fatigue, restless legs, diffuse telogen hair shedding, and impaired T4-to-T3 thyroid conversion begin whenever Ferritin drops below 30–50 ng/mL.

Action Plan: Take 25–28 mg elemental Iron Bisglycinate on alternate mornings (Mon/Wed/Fri) with Vitamin C to bypass the 24-hour hepcidin block, then re-test in 8–12 weeks.

⚠ Lab Assay & Cuff False-Alarm Check

Acute inflammation, viral illness, or fatty liver artificially elevates Ferritin (it is an acute-phase reactant). Always pair Ferritin with Fasting Transferrin Saturation (TSAT) and hs-CRP.

Specialty Directory

Anemia, Clotting & Blood Disorders Guides (88)

Clear Filter × Page 2 of 3

Hemophilia A

Hemophilia A (ICD-10-CM D66) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Hemophilia B

Hemophilia B (ICD-10-CM D67) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Henoch-Schonlein purpura (HSP)

Also called: Henoch-Schonlein purpura

Henoch-Schonlein purpura (HSP)—coded clinically as D69.0 across Blood & Anemia guidelines—combines hematologic genetic/coagulation workup [Henoch-Schonlein purpura (HSP) D69.0] with structured follow-up of Vitamin B12, Folate in Henoch-Schonlein purpura (HSP) (D69.0: & Reticulocyte Count) (B12 > 500 pg/mL; appropriate marrow response (D69.0)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Hidradenoma

Hidradenoma (ICD-10-CM D23.9) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Hydatidiform mole - invasive

Also called: Mole • Molar • Nevus

Hydatidiform mole - invasive (ICD-10-CM D39.2) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Idiopathic thrombocytopenic purpura (ITP)

Also called: Idiopathic thrombocytopenic purpura

Idiopathic thrombocytopenic purpura (ITP) (ICD-10-CM D69.6) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Intrinsic factor deficiency

Intrinsic factor deficiency (ICD-10-CM D51.0) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Juvenile xanthogranuloma

Juvenile xanthogranuloma (ICD-10-CM D76.3) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Leukemoid reaction

Leukemoid reaction (ICD-10-CM D72.823) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Lipoma

Lipoma (ICD-10-CM D17.9) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Lymphangioma

Lymphangioma—coded clinically as D18.1 across Blood & Anemia guidelines—combines individualized anticoagulation or in Lymphangioma (D18.1: transfusion care) with structured follow-up of Vitamin B12, Folate in Lymphangioma (D18.1: & Reticulocyte Count) (B12 > 500 pg/mL; appropriate marrow response (D18.1)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Lymphocyte count - high

Also called: Lymphocytosis

Lymphocyte count - high (ICD-10-CM D72.820) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Lymphocyte count - low

Also called: Lymphocytopenia

Lymphocyte count - low (ICD-10-CM D72.810) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Mastocytoma

Mastocytoma (ICD-10-CM D47.09) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Meningioma

Meningioma (ICD-10-CM D49.7) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Metaplasia - myeloid

Metaplasia - myeloid (ICD-10-CM D73.1) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Monoclonal gammopathy

Monoclonal gammopathy (ICD-10-CM D47.2) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Mucinous cystadenoma

Also called: Mucoid • Mucinous • Mucus

Mucinous cystadenoma (ICD-10-CM D27.9) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Myelodysplastic Syndromes

Also called: MDS

Your bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains immature cells, called stem cells. The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting. If you have a myelodysplastic syndrome, the stem cells do not mature into healthy blood cells. Many of them die in the bone marrow. This means that you do not have enough healthy cells, which can lead to infection, anemia, or easy bleeding.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Myelofibrosis

Myelofibrosis (ICD-10-CM D75.81) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Myeloid hyperplasia

Also called: Hyperplasia • Hyperplastic • Hypertrophic

Myeloid hyperplasia (ICD-10-CM D75.89) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Myeloid maturation arrest

Also called: Development • Developed • Developing

Designated in federal medical registries as D75.89, Myeloid maturation arrest falls under Blood & Anemia management, where B12/MMA/folate [Myeloid maturation arrest D75.89] establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Neurofibroma

Neurofibroma (ICD-10-CM D36.10) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Neurofibroma - plexiform

Neurofibroma - plexiform—coded clinically as D36.10 across Blood & Anemia guidelines—combines hematologic genetic/coagulation workup [Neurofibroma - plexiform D36.10] with structured follow-up of Vitamin B12, Folate in Neurofibroma - plexiform (D36.10: & Reticulocyte Count) (B12 > 500 pg/mL; appropriate marrow response (D36.10)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Neutropenia

Neutropenia (ICD-10-CM D70.9) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Neutropenic sepsis

Neutropenic sepsis (ICD-10-CM D70.3) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Nevus - halo

Also called: Mole • Molar • Nevus

Nevus - halo (ICD-10-CM D23.9) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Nevus - spindle cell

Also called: Mole • Molar • Nevus

Nevus - spindle cell (ICD-10-CM D22.9) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Osteochondroma

Osteochondroma (ICD-10-CM D16.9) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Osteoma

Osteoma (ICD-10-CM D16.4) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Pancreatic cholera syndrome

Also called: Pancreas • Pancreatic

Pancreatic cholera syndrome (ICD-10-CM D51.8) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Paraganglioma

Also called: Glomus tumor • Fibroid • Leiomyoma

Paraganglioma (ICD-10-CM D18.00) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Paroxysmal nocturnal hemoglobinuria (PNH)

Also called: Paroxysmal nocturnal hemoglobinuria

Paroxysmal nocturnal hemoglobinuria (PNH)—coded clinically as D59.5 across Blood & Anemia guidelines—combines individualized anticoagulation or in Paroxysmal nocturnal hemoglobinuria (PNH) (D59.5: transfusion care) with structured follow-up of Hemoglobin, Hematocrit & in Paroxysmal nocturnal hemoglobinuria (PNH) (D59.5: MCV) (Hgb 13.5–17.0 (M) / 12.0–15.5 (F) g/dL (D59.5)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Platelet Disorders

Also called: Thrombocyte disorders

Platelets, also known as thrombocytes, are blood cells. They form in your bone marrow, a sponge-like tissue in your bones. Platelets play a major role in blood clotting. Normally, when one of your blood vessels is injured, you start to bleed. Your platelets will clot (clump together) to plug the hole in the blood vessel and stop the bleeding. You can have different problems with your platelets: If your blood has a low number of platelets, it is called thrombocytopenia. This can put you at risk for mild to serious bleeding. The bleeding could be external or internal. There can be various causes. If the problem is mild, you may not need treatment.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Platelets - high (thrombocytosis)

Also called: Thrombocytosis

Designated in federal medical registries as D75.839, Platelets - high (thrombocytosis) falls under Blood & Anemia management, where complete blood count in Platelets - high (thrombocytosis) (D75.839: with peripheral smear) establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Platelets - low (thrombocytopenia)

Also called: Thrombocytopenia

Platelets - low (thrombocytopenia) (ICD-10-CM D69.6) is evaluated within Anemia, Clotting & Blood Disorders using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits
Connected Clinical Ecosystem • Medications, Supplements & Specialists

Go From Diagnosis to Treatment: Connected Flagship Guides

Prescription Medications (/meds)

FDA DailyMed & NADAC Cash Price Guides

Decode tablet imprints, IR vs. ER stomach side effects, Rule-of-6 dose response curves, and $3–$9 generic cash prices.

Dietary Supplements (/supplements)

NIH ODS & Elemental Label Math Guides

Separate human RCT outcomes from social media hype—with elemental vs. compound weight decoders and serum 25(OH)D targets.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Compare U.S. specialists by real CMS Medicare Part B procedure volume, verified Google patient reviews, and accepted PPO/Medicare plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

Which diagnostic lab ranges and guidelines govern Anemia, Clotting & Blood Disorders (88 on dotMD.com?

dotMD.com maps Anemia, Clotting & Blood Disorders (88 against ADA, ACC/AHA, USPSTF, and Endocrine Society diagnostic criteria, contrasting broad 95% portal reference intervals with optimal clinical targets. Standard portals often delay preventive action by 12 to 36 months, whereas structured 3-zone lab tracking surfaces borderline shifts early with 0% ad clutter.

Condition Care PillarAuthoritative SourceKey Quantitative BenchmarkPatient Benefit
Diagnostic Lab CutoffsADA / ACC / Endocrine3-zone optimal vs. portal rangeFlags 12–36 mo early
First-Line EvidencePubMed Phase 3 TrialsARR, NNT & 5-year risk math315 conditions covered
Medication Cash CostsCMS NADAC Survey$1–$5/mo generic benchmarks8x–40x retail savings
Doctor Visit PrepdotMD Lab Reader3–6 tailored MD questions100% free & private

How should patients prepare lab numbers and questions for a Anemia, Clotting & Blood Disorders (88 visit?

dotMD.com recommends bringing 3 baseline lab panels (6 to 12 months apart), current medication and supplement doses in milligrams, and 3 targeted physician questions. Auditing treatment options by Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) clarifies real 5-year benefit in under 5 mins.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee